دورية أكاديمية
Management of portal hypertension in patients receiving atezolizumab-bevacizumab for hepatocellular carcinoma
| العنوان: | Management of portal hypertension in patients receiving atezolizumab-bevacizumab for hepatocellular carcinoma |
|---|---|
| المؤلفون: | Tovoli, F., Franceschini, E., Vivaldi, C., Federico, P., Palloni, A., Dalbeni, A., Soldà, C., Stefanini, B., Garajova, I., Ielasi, L., De Lorenzo, S., Granito, A., Chen, R., Masi, G., Lonardi, S., Brandi, G., Daniele, B., Sacerdoti, D., Lani, L., Svegliati-Baroni, G., Campani, C., Piscaglia, F. |
| المصدر: | Digestive and Liver Disease ; volume 56, page S87 ; ISSN 1590-8658 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2024 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Gastroenterology, Hepatology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.dld.2024.01.152 |
| الإتاحة: | https://doi.org/10.1016/j.dld.2024.01.152Test https://api.elsevier.com/content/article/PII:S1590865824001531?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S1590865824001531?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.92A23FAF |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.dld.2024.01.152 |
|---|